Literature DB >> 29059167

Loss of RhoA promotes skin tumor formation and invasion by upregulation of RhoB.

A García-Mariscal1, H Li1, E Pedersen1, K Peyrollier1, K M Ryan2, A Stanley3, F Quondamatteo3, C Brakebusch1.   

Abstract

Cellular movement is controlled by small GTPases, such as RhoA. Although migration is crucial for cancer cell invasion, the specific role of RhoA in tumor formation is unclear. Inducing skin tumors in mice with a keratinocyte-restricted loss of RhoA, we observed increased tumor frequency, growth and invasion. In vitro invasion assays revealed that in the absence of RhoA cell invasiveness is increased in a Rho-associated protein kinase (ROCK) activation and cell contraction-dependent manner. Surprisingly, loss of RhoA causes increased Rho signaling via overcompensation by RhoB because of reduced lysosomal degradation of RhoB in Gamma-aminobutyric acid receptor-associated protein (GABARAP)+ autophagosomes and endosomes. In the absence of RhoA, RhoB relocalized to the plasma membrane and functionally replaced RhoA with respect to invasion, clonogenic growth and survival. Our data demonstrate for the first time that RhoA is a tumor suppressor in 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol 13-acetate skin carcinogenesis and identify Rho signaling dependent on RhoA and RhoB as a potent driver of tumor progression.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29059167     DOI: 10.1038/onc.2017.333

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  49 in total

1.  Rac1 is crucial for Ras-dependent skin tumor formation by controlling Pak1-Mek-Erk hyperactivation and hyperproliferation in vivo.

Authors:  Z Wang; E Pedersen; A Basse; T Lefever; K Peyrollier; S Kapoor; Q Mei; R Karlsson; A Chrostek-Grashoff; C Brakebusch
Journal:  Oncogene       Date:  2010-04-12       Impact factor: 9.867

Review 2.  Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility.

Authors:  Ann P Wheeler; Anne J Ridley
Journal:  Exp Cell Res       Date:  2004-11-15       Impact factor: 3.905

3.  Structural determinants allowing endolysosomal sorting and degradation of endosomal GTPases.

Authors:  Ruth A Valero; Clara L Oeste; Konstantinos Stamatakis; Irene Ramos; Mónica Herrera; Patricia Boya; Dolores Pérez-Sala
Journal:  Traffic       Date:  2010-06-21       Impact factor: 6.215

4.  RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells.

Authors:  A X Liu; N Rane; J P Liu; G C Prendergast
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

5.  Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells.

Authors:  Julien Mazières; Vanessa Tillement; Cuider Allal; Carine Clanet; Lisbeth Bobin; Zhi Chen; Said M Sebti; Gilles Favre; Anne Pradines
Journal:  Exp Cell Res       Date:  2004-12-28       Impact factor: 3.905

6.  Variegated RHOA mutations in adult T-cell leukemia/lymphoma.

Authors:  Yasunobu Nagata; Kenji Kontani; Terukazu Enami; Keisuke Kataoka; Ryohei Ishii; Yasushi Totoki; Tatsuki R Kataoka; Masahiro Hirata; Kazuhiro Aoki; Kazumi Nakano; Akira Kitanaka; Mamiko Sakata-Yanagimoto; Sachiko Egami; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Yusuke Shiozawa; Tetsuichi Yoshizato; Hiromichi Suzuki; Ayana Kon; Kenichi Yoshida; Yusuke Sato; Aiko Sato-Otsubo; Masashi Sanada; Wataru Munakata; Hiromi Nakamura; Natsuko Hama; Satoru Miyano; Osamu Nureki; Tatsuhiro Shibata; Hironori Haga; Kazuya Shimoda; Toshiaki Katada; Shigeru Chiba; Toshiki Watanabe; Seishi Ogawa
Journal:  Blood       Date:  2015-11-16       Impact factor: 22.113

7.  RhoA is dispensable for skin development, but crucial for contraction and directed migration of keratinocytes.

Authors:  Ben Jackson; Karine Peyrollier; Esben Pedersen; Astrid Basse; Richard Karlsson; Zhipeng Wang; Tine Lefever; Alexandra M Ochsenbein; Gudula Schmidt; Klaus Aktories; Alanna Stanley; Fabio Quondamatteo; Markus Ladwein; Klemens Rottner; Jolanda van Hengel; Cord Brakebusch
Journal:  Mol Biol Cell       Date:  2011-01-05       Impact factor: 4.138

8.  RhoA and RhoC have distinct roles in migration and invasion by acting through different targets.

Authors:  Francisco M Vega; Gilbert Fruhwirth; Tony Ng; Anne J Ridley
Journal:  J Cell Biol       Date:  2011-05-16       Impact factor: 10.539

Review 9.  Actomyosin stress fiber mechanosensing in 2D and 3D.

Authors:  Stacey Lee; Sanjay Kumar
Journal:  F1000Res       Date:  2016-09-07

10.  Distinct roles of MLCK and ROCK in the regulation of membrane protrusions and focal adhesion dynamics during cell migration of fibroblasts.

Authors:  Go Totsukawa; Yue Wu; Yasuharu Sasaki; David J Hartshorne; Yoshihiko Yamakita; Shigeko Yamashiro; Fumio Matsumura
Journal:  J Cell Biol       Date:  2004-02-02       Impact factor: 10.539

View more
  18 in total

1.  ΔNp63α Suppresses TGFB2 Expression and RHOA Activity to Drive Cell Proliferation in Squamous Cell Carcinomas.

Authors:  Christopher G Abraham; Michael P Ludwig; Zdenek Andrysik; Ahwan Pandey; Molishree Joshi; Matthew D Galbraith; Kelly D Sullivan; Joaquin M Espinosa
Journal:  Cell Rep       Date:  2018-09-18       Impact factor: 9.423

2.  RAS induced senescence of skin keratinocytes is mediated through Rho-associated protein kinase (ROCK).

Authors:  Alex J Lee; Elise Fraser; Brittany Flowers; Jee Kim; Kenneth Wong; Christophe Cataisson; Huaitian Liu; Howard Yang; Maxwell P Lee; Stuart H Yuspa; Luowei Li
Journal:  Mol Carcinog       Date:  2021-09-17       Impact factor: 5.139

3.  CCM3 is a gatekeeper in focal adhesions regulating mechanotransduction and YAP/TAZ signalling.

Authors:  Shan Wang; Emelie Englund; Pontus Kjellman; Zhen Li; Johannes Kumra Ahnlide; Carmen Rodriguez-Cupello; Mattia Saggioro; Ryu Kanzaki; Kristian Pietras; David Lindgren; Håkan Axelson; Christelle N Prinz; Vinay Swaminathan; Chris D Madsen
Journal:  Nat Cell Biol       Date:  2021-07-05       Impact factor: 28.824

Review 4.  Rho GTPases in cancer: friend or foe?

Authors:  Julius H Svensmark; Cord Brakebusch
Journal:  Oncogene       Date:  2019-08-19       Impact factor: 9.867

5.  ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma.

Authors:  Yalu Liu; Xiaogan Wang; Lijuan Deng; Lingyan Ping; Yunfei Shi; Wen Zheng; Ningjing Lin; Xiaopei Wang; Meifeng Tu; Yan Xie; Weiping Liu; Zhitao Ying; Chen Zhang; Zhengying Pan; Xi Wang; Ning Ding; Yuqin Song; Jun Zhu
Journal:  Cancer Cell Int       Date:  2019-02-14       Impact factor: 5.722

6.  An RNAi screen unravels the complexities of Rho GTPase networks in skin morphogenesis.

Authors:  Melanie Laurin; Nicholas C Gomez; John Levorse; Ataman Sendoel; Megan Sribour; Elaine Fuchs
Journal:  Elife       Date:  2019-09-25       Impact factor: 8.140

7.  Effects of RhoA and RhoC upon the sensitivity of prostate cancer cells to glutamine deprivation.

Authors:  Luciana Bueno De Paiva; Vanessa Aline Bernusso; João Agostinho Machado-Neto; Fabiola Traina; Anne J Ridley; Sara Teresinha Olalla-Saad; Mariana Lazarini
Journal:  Small GTPases       Date:  2018-11-18

Review 8.  LncRNAs regulate the cytoskeleton and related Rho/ROCK signaling in cancer metastasis.

Authors:  Yanyan Tang; Yi He; Ping Zhang; Jinpeng Wang; Chunmei Fan; Liting Yang; Fang Xiong; Shanshan Zhang; Zhaojian Gong; Shaolin Nie; Qianjin Liao; Xiayu Li; Xiaoling Li; Yong Li; Guiyuan Li; Zhaoyang Zeng; Wei Xiong; Can Guo
Journal:  Mol Cancer       Date:  2018-04-04       Impact factor: 27.401

9.  BNIP-2 retards breast cancer cell migration by coupling microtubule-mediated GEF-H1 and RhoA activation.

Authors:  Meng Pan; Ti Weng Chew; Darren Chen Pei Wong; Jingwei Xiao; Hui Ting Ong; Jasmine Fei Li Chin; Boon Chuan Low
Journal:  Sci Adv       Date:  2020-07-31       Impact factor: 14.136

10.  KIF13A-regulated RhoB plasma membrane localization governs membrane blebbing and blebby amoeboid cell migration.

Authors:  Xiaowei Gong; Yuliia Didan; John G Lock; Staffan Strömblad
Journal:  EMBO J       Date:  2018-07-26       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.